sr141716 has been researched along with Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Guan, D; Jiang, S; Li, S; Liu, M; Tian, Z; Wang, L; Zhang, M | 1 |
| Azzarone, B; Beaudreuil, S; Charpentier, B; Chatziantoniou, C; Dalia, M; Desterke, C; Devocelle, A; Durrbach, A; Ferlicot, S; François, H; Giron-Michel, J; Grassin-Delyle, S; Ivanovski, N; Lecru, L; Ledent, C; Saïd, M; Vandermeersch, S; Vazquez, A; Vernochet, A | 1 |
1 review(s) available for sr141716 and Cirrhosis
| Article | Year |
|---|---|
[Research progress of role of cannabinoid receptor in fibrosis].
Topics: Animals; Cannabinoid Receptor Antagonists; Cannabinoids; Fibrosis; Humans; Liver Cirrhosis; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Rimonabant; Scleroderma, Diffuse; Signal Transduction; Skin; Smad Proteins; Transforming Growth Factor beta1 | 2014 |
1 other study(ies) available for sr141716 and Cirrhosis
| Article | Year |
|---|---|
Cannabinoid receptor 1 is a major mediator of renal fibrosis.
Topics: Acute Disease; Animals; Arachidonic Acids; Cells, Cultured; Chemokine CCL2; Collagen; Diabetes Mellitus; Disease Models, Animal; Endocannabinoids; Fibrosis; Gene Expression Profiling; Glomerulonephritis, IGA; Glycerides; Humans; Kidney; Ligands; Macrophages; Mice; Mice, Knockout; Myofibroblasts; Nephritis, Interstitial; Oligonucleotide Array Sequence Analysis; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; RNA, Messenger; Transforming Growth Factor beta1; Up-Regulation; Ureteral Obstruction | 2015 |